Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria · Delayed Price · Currency is NGN 11.00
+0.35 (3.29%)
At close: Mar 5, 2026
NGX:NEIMETH Revenue
In the year 2025, Neimeth International Pharmaceuticals had annual revenue of 7.37B NGN with 64.29% growth. Neimeth International Pharmaceuticals had revenue of 2.36B in the quarter ending December 31, 2025, with 69.59% growth.
Revenue
7.37B
Revenue Growth
+64.29%
P/S Ratio
6.38
Revenue / Employee
42.11M
Employees
175
Market Cap
47.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.37B | 2.88B | 64.29% |
| Dec 31, 2024 | 4.49B | 2.28B | 102.98% |
| Dec 31, 2023 | 2.21B | -709.73M | -24.31% |
| Dec 31, 2022 | 2.92B | 216.47M | 8.01% |
| Sep 30, 2022 | 2.70B | -343.81M | -11.28% |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Eterna | 302.52B |
| CWG Plc | 65.66B |
| Consolidated Hallmark Holdings | 51.65B |
| Sovereign Trust Insurance | 46.35B |
| Linkage Assurance | 26.78B |
| NPF Microfinance Bank | 17.55B |
| Chams Holding Company | 17.50B |
| Africa Prudential | 7.47B |